Concurrent chemotherapy and radiation for locally advanced cervical cancer: the new standard of care (Q33835947)

29 July 2017

1 reference

title

Concurrent chemotherapy and radiation for locally advanced cervical cancer: the new standard of care (English)

1 reference

29 July 2017

1 reference

cervix uterine cancer

1 reference

Thomas GM

1

1 reference

29 July 2017

1 January 2000

1 reference

Seminars in Radiation Oncology

29 July 2017

1 reference

29 July 2017

10

1 reference

29 July 2017

1

1 reference

29 July 2017

44-50

1 reference

Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

Carcinoma of the cervix--anaemia, radiotherapy and hyperbaric oxygen

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

Chemotherapy Followed by Radiotherapy versus Radiotherapy Alone in Locally Advanced Cervical Cancer: A Randomized Study

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

Intraarterial cisplatin and concurrent radiation for locally advanced bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

A randomized trial comparing platinum-based chemotherapy followed by radiotherapy vs. radiotherapy alone in patients with locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

Neoadjuvant chemotherapy in locally advanced cervical cancer: two randomised studies

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

Hydroxyurea or placebo combined with radiation to treat stages iiib and iv cervical cancer confined to the pelvis

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

Long-term follow-up of potentiation of radiotherapy by cis-platinum in advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. GONO (North-West Oncologic Cooperative Group)

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group stud

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980020-X

7 January 2021

10.1016/S1053-4296(00)80020-X

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10671658